Chylous ascites secondary to hyperlipidemic pancreatitis with normal serum amylase and lipase

World Journal of Gastroenterology

Volumn 13, Issue 3, 2007, Pages 480-482

  Khan, Fahmi Yousef ^a   Matar, Issa ^a  

^a HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

Amylase; Chylous ascites; Hyperlipidemic pancreatitis

Indexed keywords

GEMFIBROZIL; PETHIDINE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ABDOMINAL SCINTISCANNING; ADULT; AMYLASE BLOOD LEVEL; ARTICLE; CASE REPORT; CHYLOUS ASCITES; CLINICAL FEATURE; HUMAN; HYPERLIPIDEMIA; LOW FAT DIET; MALE; NAUSEA; PARACENTESIS; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; VOMITING;

EID: 33846578257     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i3.480     Document Type: Article

References (20)

1. Fallat RW, Vester JW, Glueck CJ. Suppression of amylase activity by hypertriglyceridemia. JAMA 1973; 225: 1331-1334
2. Ben-Ami H, Nagachandran P, Assalia A, Edoute Y. Acute transient chylous ascites associated with acute biliary pancreatitis. Am J Med Sci 1999; 318: 122-123
3. Steinberg W, Goldstein S, Davis N. Diagnostic assays in acute pancreatitis. Ann Intern Med 1985; 103: 475-476
4. Wong EC, Butch AW, Rosenblum JL. The clinical chemistry laboratory and acute pancreatitis. Clin Chem 1993; 39: 234-243
5. Greenberger NJ, Toskes PP. Approach to the patient with pancreatic disease. In: Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS, eds. Harrison's principles of internal medicine. New York: McGraw Hill, 1987: 1368-1372
6. Fortson MR, Freedman SN, Webster PD 3rd. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol 1995; 90: 2134-2139
7. Piolot A, Nadler F, Cavallero E, Coquard JL, Jacotot B. Prevention of recurrent acute pancreatitis in patients with severe hypertriglyceridemia: value of regular plasmapheresis. Pancreas 1996; 13: 96-99
8. Tenner S, Banks PA. Acute pancreatitis: nonsurgical management. World J Surg 1997; 21: 143-148
9. Cardenas A, Chopra S. Chylous ascites. Am J Gastroenterol 2002; 97: 1896-1900
10. Press OW, Press NO, Kaufman SD. Evaluation and management of chylous ascites. Ann Intern Med 1982; 96: 358-364
11. Runyon BA, Akriviadis EA, Keyser AJ. The opacity of portal hypertension-related ascites correlates with the fluid's triglyceride concentration. Am J Clin Pathol 1991; 96: 142-143
12. Jungst D, Gerbes AL, Martin R, Paumgartner G. Value of ascitic lipids in the differentiation between cirrhotic and malignant ascites. Hepatology 1986; 6: 239-243
13. Kelley ML Jr, Butt HR. Chylous ascites: an analysis of its etiology. Gastroenterology 1960; 39: 161-170
14. Browse NL, Wilson NM, Russo F, al-Hassan H, Allen DR. Aetiology and treatment of chylous ascites. Br J Surg 1992; 79: 1145-1150
15. Goldfarb JP. Chylous effusions secondary to pancreatitis: case report and review of the literature. Am J Gastroenterol 1984; 79: 133-135
16. Variyam EP. Central vein-hyperalimentation in pancreatic ascites. Am J Gastroenterol 1983; 78: 178-181
17. Stone LD. Pancreatic ascites. Br J Hosp Med 1986; 35: 252-253
18. Oktedalen O, Nygaard K, Osnes M. Somatostatin in the treatment of pancreatic ascites. Gastroenterology 1990; 99: 1520-1521
19. Uhl W, Anghelacopoulos SE, Friess H, Buchler MW. The role of octreotide and somatostatin in acute and chronic pancreatitis. Digestion 1999; 60 Suppl 2: 23-31
20. Gomez-Cerezo J, Barbado Cano A, Suarez I, Soto A, Rios JJ, Vazquez JJ. Pancreatic ascites: study of therapeutic options by analysis of case reports and case series between the years 1975 and 2000. Am J Gastroenterol 2003; 98: 568-577